Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
GENinCode UK Ltd. ( (GB:GENI) ) has shared an update.
GENinCode UK Ltd. has announced a collaboration with Thermo Fisher Scientific to sell, distribute, and manufacture its CARDIO inCode-Score® test, which predicts genetic risk for coronary heart disease. This partnership aims to expand the test’s availability across the US and EMEA regions, leveraging Thermo Fisher’s manufacturing capabilities and distribution network. The collaboration is expected to enhance GENinCode’s market presence and accelerate the adoption of its test, which has already received New York State licensure and is included in the US Clinical Laboratory Fee Schedule. The move is part of GENinCode’s broader strategy to expand its commercial footprint and improve public health outcomes by integrating genetic risk assessments into clinical pathways.
The most recent analyst rating on (GB:GENI) stock is a Sell with a £2.00 price target. To see the full list of analyst forecasts on GENinCode UK Ltd. stock, see the GB:GENI Stock Forecast page.
Spark’s Take on GB:GENI Stock
According to Spark, TipRanks’ AI Analyst, GB:GENI is a Underperform.
The overall stock score is heavily influenced by the company’s financial struggles, including persistent losses and negative cash flows. Technical analysis further supports a bearish outlook, with the stock showing weak momentum. Valuation metrics are also unfavorable, with a negative P/E ratio and no dividend yield.
To see Spark’s full report on GB:GENI stock, click here.
More about GENinCode UK Ltd.
GENinCode UK Ltd. is a predictive genetics company based in Oxford, focusing on the prevention of cardiovascular disease and risk assessment of ovarian cancer. The company is known for its CARDIO inCode-Score® test, which predicts and prevents coronary heart disease by assessing genetic risk.
Average Trading Volume: 1,091,365
Technical Sentiment Signal: Strong Sell
Current Market Cap: £6.17M
See more insights into GENI stock on TipRanks’ Stock Analysis page.